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Purpose: Cerebral hamartomas are lesions marked by a disorganized arrangement of mature neural elements and represent a
rare cause of medically intractable focal epilepsy. We present the clinical presentation and imaging findings of this rare entity.
Methods: History and neurophysiological studies of 14 patients with pathologically confirmed hamartomas who had surgery
for intractable focal epilepsy were reviewed. MRIs were available for review in 10 patients.
Results: The lesions were most commonly located in the temporal and frontal lobes. Seizure semiology was concordant with
the anatomic location of the hamartoma in all patients. Nine of the thirteen patients (69%) with the hamartoma confined to one
lobe had interictal spikes and sharp waves at the corresponding electrodes. The ictal pattern was confined to the same lobe of the
hamartoma in five of nine patients with ictal recordings. Although imaging characteristics were variable, all patients had signal
increase on T2-weighted images and 50% of them had mild mass effect. Neocortical involvement was present in the majority of
patients (7/10), blurring of the gray/white matter interface was seen in seven patients. Five of those seven patients were found
to have associated cortical dysplasia by pathology.
Conclusion: Hamartomas represent a rare entity and may cause devastating epilepsy. Imaging characteristics are difficult to
distinguish from those of some other developmental tumors. Hamartomas are frequently associated with microscopic cortical
dysplasia (CD), thus underlining their malformative etiology.
© 2002 BEA Trading Ltd. Published by Elsevier Science Ltd. All rights reserved.
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INTRODUCTION
Cerebral hamartomas are defined as lesions com-
posed of disorganized but mature cells, mostly a
combination of neuronal or ganglion cells, glial cells
and blood vessels. They represent a rare cause of
medically intractable focal epilepsy. In pathologi-
cal series of patients operated on for epilepsy, be-
tween 2.81 and 3.2%2 of all patients had glioneural
hamartomas.
The MR-imaging characteristics are not well de-
fined, mostly because hamartomas represent a rare
entity. The objective of the study was to better
characterize the imaging findings and clinicopatho-
logical correlation in patients with chronic epilepsy
secondary to pathologically proven hamartomatous
lesions.
METHODS
We retrospectively reviewed 14 patients who under-
went surgery for epilepsy between 1991 and 1999
with a histological diagnosis of hamartomas. Presur-
gical assessment of all patients included history,
physical examination, neuropsychological testing,
prolonged video-EEG telemetry and MR-imaging.
The MRI studies were performed on a 1.5T MR
(Vision, Siemens, Erlangen, Germany) system us-
ing a conventional, circularly polarized head coil.
Sagittal T1, coronal conventional spin-echo T2,
coronal MPRAGE (magnetization-prepared rapid
gradient echo) and axial FLAIR or spin-echo
T2 images were obtained. MRI scans were re-
viewed by two experienced raters (PR and IN).
The histological criteria for diagnosis and detailed







Patient # Location of lesion Age at Age at sz semiology sz frequency Interictal epileptiform Ictal abnormalities Surgery Outcome at time
onset surgery abnormalities after surgery
1 Left temporala 20 22 Complex partial (automotor) sz-GTS 2–3 per month Left mesial temporal SW Left temporal Left temporal lobectomy I (1 year)
2 Right frontala 11 33 Abdominal aura-complex partial
(bilateral asymmetric tonic) sz
Clusters, 90 per day Right frontal spikes and SW Non-localizable Right frontal lobectomy I (5 years)
3 Right hemispherea 1 6 Tonic (bilateral asymmetric tonic)
sz-complex partial (automotor) sz.
Seven years later: psychicaura-tonic
(left face tonic) sz
3–4 per day Surface EEG: no epileptiform
abnormalities
Surface EEG: suppression right
fronto-parietal region PEG:
orbital, anterior and mesial
frontal region after surgery:
right fronto-temporal
Right frontal lobectomy IV (8 years) continues
sz arising from right
frontal region (about
2 per day)
4 Right frontala 2 8 Complex partial (automotor) sz 1 per day Right > left frontal SW Lateralized right hemisphere Right frontal lobectomy I (6 months)
5 Right frontala 26 32 Simple partial sz with motor
symptoms-version (left versive
sz)-GTS
1 per month Right frontal SW None recorded Right frontal lobectomy I (4 years)
6 Left frontala 2 14 Simple partial sz (non-specific
aura)-simple partial sz with motor
symptoms (bilateral arm tonic-right
arm clonic)
6–8 per day Left frontal > right frontal SW Left fronto-central Left frontal lobectomy I (1 year)
7 Left occipitala 13 27 (1) Complex partial (dialeptic) sz;
(2) psychic aura-visual aura-complex
partial (automotor) sz
1 per day Left temporal SW Left parietooccipital Invasive
recording: left occipitotemporal
Left occipital lesionectomy I (1 year)
8 Left temporala 13 17 Abdominal aura-complex partial
(automotor) sz
2–3 per week to 3–4
per day
Left temporal SW Regional left temporal or
lateralized left hemisphere
Left temporal lobectomy IV (died in status
2 years later)
9 Left temporala 38 Aura-complex partial (automotor) sz 2 per week Left temporal SW None recorded Left temporal lobectomy No follow-up available
10 Right temporala 25 Olfactory aura-complex partial
(automotor) sz
3–4 per month Normal No recording Right temporal lobectomy I (4 years)
11 Right temporal 10 30 Complex partial (automotor) sz 2–3 per day Right temporal SW Obscured Right temporal lobectomy I (9 years)
12 Right temporal 22 29 Auditory aura-complex partial
(automotor) sz-GTS
2 per week Bitemporal SW, right > left None recorded Right temporal lobectomy I (1 year)
13 Left frontal 2 15 (1) Simple partial sz with motor
symptoms (bilateral arm tonic-right
face clonic sz); (2) complex partial
(automotor) sz-GTS
5–7 per week Left frontal spikes Lateralized left hemisphere Left frontal lobectomy IV (died in status
2 years after surgery)
14 Left temporal 16 31 Complex partial (automotor) sz 2–3 per month None None recorded Left temporal lobectomy I (2 years)
a Imaging reviewed, see Table 2. SW: sharp wave; GTS: generalized tonic-clonic seizure; sz: seizure. In parenthesis: semiological seizure classification if different from International classification.
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pathology of some of the patients was described
previously3.
RESULTS
Clinical and neurophysiological data
The hamartomas were localized in one lobe in 13 of
the 14 patients, 7 were in the temporal, 5 in the frontal
lobe and 1 in the occipital lobe. Please see Table 1
for detailed clinical data. None of the patients had the
clinical features of tuberous sclerosis and none had
multiple brain lesions identified on MRI.
Mean age of seizure onset was 11.1 ± 7.9 years,
mean age at surgery was 23.4±10 years. Seizure semi-
ology was concordant with the anatomic location of
the hamartoma in all patients. Seizure frequency was
variable (one to five seizures per day in seven patients,
two to four per week in three patients, one to four
per month in four patients). Interictal EEGs revealed
epileptiform activity in all but three patients. Nine of
the thirteen patients (69%) with the hamartoma con-
fined to one lobe had interictal spikes and sharp waves
at the corresponding electrodes. Two of those thir-
teen patients had no interictal epileptiform activity,
one patient with temporal lobe epilepsy had bitem-
poral spikes, one patient with frontal lobe epilepsy
had bifrontal spikes. Ictal recordings were obtained
in nine patients. The ictal pattern was confined to the
same lobe of the hamartoma in five patients, later-
alized to the ipsilateral hemisphere in two patients,
non-localizable in one patient, or obscured by artifact
in one patient.
Neuropsychological testing revealed comprehen-
sive IQs from 76 to 113 (median 93). Two patients
were described as mentally retarded without detailed
neuropsychological testing. Neurological examina-
Table 2:




1 Left amygdala, extending
into hippocampal body
Isointense Yes No Yes Yes Yes
2 Right mesial frontal No No No Yes (dysmorphic gyri) Yes
3 Right hemisphere Isointense (NH) Not given Yes No Yes (variable gray matter
thickness)
Yes
4 Right frontal pole Isointense No No No Yes Yes
5 Right anterior frontal (NH) No No No Yes (dysmorphic gyri) Yes
6 Left inferior frontal sulcus Isointense No No No Yes (dysmorphic gyri) Yes
7 Left occipital Isointense (NH) No No Yes Yes Yes
8 Left hippocampus Isointense (NH) No Yes Yes No No
9 Left amygdala No No Yes No No
10 Right anterior and mesial
temporal
(NH) Yes No Yes No No
NH: non-homogeneous.
tion was abnormal in two patients concordant with
the lesion.
Postoperative seizure outcome was good in 10
patients (seizure free at 6 months to 9 years af-
ter surgery). One patient was lost in follow-up,
three had recurrent seizures despite gross removal
of the hamartoma as evidenced by postoperative
MRI. Two patients died in status epilepticus several
years after their surgery at ages 17 and 19 years,
respectively.
MR imaging characteristics
MRI scans of 10/14 patients were available for review,
findings are displayed in Table 2. The lesions were
located in the mesial temporal lobe in four patients
(see Fig. 1), and in the frontal lobe in four patients (see
Fig. 2). One patient had an occipital hamartoma and
another one had more widespread right hemispheric
involvement.
On T1-weighted images, the lesion was isointense to
gray matter in six patients, hyperintense in two and hy-
pointense in two. On T2-weighted images, all patients
had signal increase (non-homogeneously in five). Of
the nine patients who received gadolinium, two pa-
tients showed mild enhancement. Cysts were present
in two patients. Mild mass effect was seen in five
patients. Neocortical involvement was present in the
majority of patients (7/10), blurring of the gray/white
matter interface was seen in seven patients. Five of
those seven patients were found to have associated
cortical dysplasia by pathology.
Reports of the MRIs of the remaining four patients
were reviewed, three had temporal masses, one frontal.
All had increased signal in T2-weighted images. En-
hancement was present in one of two patients who had
gadolinium administered.
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Fig. 1: MRI of a 22 years woman with intractable temporal lobe epilepsy secondary to a hamartoma. The patient had two to three
complex partial seizures per month with rare secondary generalization since the age of 19 years. The MRI shows a mass in the
left amygdala and hippocampal body. Signal characteristics are: isointense on T1 (A), hyperintense on T2 and FLAIR (B and C).
Fig. 2: MRI of a 33-year-old woman with bilateral asymmetric tonic seizures since the age of 11 years. The MRI shows a mass in
the right superior frontal gyrus. Signal characteristics are: mildly hyperintense on T1 (A and C), hyperintense on spin-density (B).
Pathology results
As previously described, the pathological features
included a circumscribed, disorganized collection of
glial cells, primarily astrocytes3. Associated micro-
scopic cortical dysplasia was found in seven patients.
Two patients died in status epilepticus: one patient
died 3 years after left frontal lobe resection; pathol-
ogy showed dysplasia of the remaining left frontal
lobe. The contralateral frontal lobe, right parietal and
left occipital lobes were normal. The second patient
had a history of generalized status epilepticus prior
to surgery. The pathological examination of frontal,
temporal and parietal lobes revealed global ischemic
changes and acute infarcts.
DISCUSSION
The nomenclature of malformative brain lesions has
remained variable and the distinction between forms
of glioneuronal malformations such as hamartomas,
DNETs and gangliogliomas is not always clear4–6.
Those lesions share the fact that they represent a
tumor-like, not primarily neoplastic malformation.
They are frequently associated with microscopic cor-
tical dysplasia, thus underlining the malformative
etiology7.
Gangliogliomas and hamartomas both have mixed
glial and neuronal cell elements and may have eosi-
nophilic granular bodies, but the degree of cytologi-
cal atypia is different. DNETs have a multinodular
configuration, mostly consisting of oligodendroglial-
like cells, whereas the hamartomas in this series con-
sist of astrocytic cells. Given the similarities between
those three lesions, it can be argued that they represent
a spectrum and sometimes may be difficult to distin-
guish from one another.
Gomez-Anson et al.8 described the imaging char-
acteristics of two patients with temporal lobe hamar-
tomas. One patient had a center of low T1 and T2
signal in the core of the lesion, and surrounding high
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signal intensity. The second patient had an irregularly
calcified, non-enhancing mass on CT, no MRI was
done.
Most of our patients showed high signal on T2-
weighted imaging with mild mass effect in 50% of
cases. Gadolinium enhancement was rare. Signal char-
acteristics on T1 were less homogeneous, however the
majority of patients appeared isointense on T1. Gray
white matter blurring was relatively frequent (70% of
our patients). Seventy-one percent of those patients
had associated cortical dysplasia, a known reason for
loss of gray white matter differentiation on MRI8, 9.
Nearly all of those lesions had the appearance of
well-defined masses on MRI. Typical locations were
the mesial temporal and frontal lobes. Cysts were seen,
but less frequently than in other developmental tumors
such as gangliogliomas. Since we did not review CT
scans, we are not able to comment on the frequency
of calcifications.
Raymond et al.10 described imaging characteris-
tics of fourteen patients with histologically proven
DNETs. The lesions were located in the temporal lobe
in 13 patients and in the cingulum in 1. Signal charac-
teristics were hypointense on T1-weighted images in
all but two patients, and hyperintense on T2-weighted
images in all patients. Six of eight patients who re-
ceived gadolinium had some enhancement, 5 of 14
had cystic component, and 6 had gray white blurring.
These results are almost identical to the imaging char-
acteristics of our patients with hamartomas. This may
reflect the fact that DNET and hamartomas have many
histological similarities.
The clinical spectrum included a wide range from
clinically and developmentally normal individuals to
mentally retarded patients. The epilepsy also ranged
from rather infrequent seizures to devastating epilepsy
with multiple daily seizures. Interictal and ictal activ-
ity was concordant with the tumor in the majority of
cases. Outcome data in this study with 71% seizure
freedom were comparable with other series9. The fact
that two young patients died in status epilepticus years
after surgery shows however the potential seriousness
of the hamartoma-induced epileptogenicity and sug-
gests an aggressive approach towards the treatment of
these lesions. Further studies are needed to elucidate
the cellular characteristics of these lesions and the
mechanisms of hamartoma-induced epileptogenicity.
CONCLUSION
Hamartomas represent a rare entity and may cause
devastating epilepsy. Imaging characteristics are diffi-
cult to distinguish from those of some other develop-
mental tumors. Hamartomas are frequently associated
with microscopic cortical dysplasia (CD), thus under-
lining their malformative etiology. Surgical resection
will result in seizure freedom in the majority of cases
(70%), however some patients may have recurrent
seizures.
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